Clinical Genomics develops innovative products for colorectal cancer diagnosis. Our passion is to introduce advanced healthcare solutions to address unmet needs. With a broad intellectual property portfolio including more than 95 patents, Clinical Genomics delivers products to improve early cancer detection and cancer recurrence monitoring.
Clinical Genomics has developed a genomic blood test to diagnose colorectal cancer RECURRENCE at the earliest, most treatable stages.
Clinical Genomics is investing in technologies and clinical research that deliver better options to healthcare practitioners and lead to improved clinical outcomes for patients.